|
||
|
Venture capital firms and funds in Europe 128 Venture Capital Group 3i Venture Capital Accuitive Medical Acer Venture Capital Act Venture Capital Ltd Adelaide Venture Capital Email ADS Ventures Boston Advantages Of Venture Capital Advent Venture Capital Agio Capital Alabama Venture Capital Alaska Venture Capital All Stages Venture Capital American Venture Capital Analysis Venture Capital Analyze Venture Capital Angel Capital Appraisal Venture Capital Arch Venture Capital Argentina Venture Capital Arizona Venture Capital Arkansas Venture Capital Arrowpath Venture Capital Assess Venture Capital Assessment Venture Capital Atlas Venture Capital ATV Venture Capital Aurora Fund Australia Venture Capital Austria Venture Capital Automotive Venture Capital AZ Venture Capital VCgate More Venture Capital Terms and Topics
-
Sadra Medical Raises $19 Million in Series B Financing
October 24th, 2006 No comments
Sadra Medical, a privately-held, development stage Silicon Valley firm dedicated to developing innovative new therapies for aortic valve disease, has recently completed a $19 Million Series B round of funding. Oakwood Medical Investors and Boston Scientific joined the company’s Series A investors, Pequot Ventures, Onset Ventures and SV Life Sciences Advisors (SVLS), in the financing.
“We are pleased to be backed by the deep experience base of our investors. Their support will help us in attaining our goal of delivering the best device possible to make percutaneous aortic valve replacement a viable therapeutic option for patients in need,” stated Amr Salahieh, President and CEO of Sadra Medical. “Our momentum is building and we look forward to initiating clinical evaluation of the Sadra Lotusā¢ Valve within the next several months.”
Raul Perez, president of Oakwood Medical, observed, “We believe percutaneous aortic valve replacement will play a significant therapeutic role in the future. This investment in Sadra Medical reflects the consensus of the group of investors that the innovativeĀ second-generation repositionable Lotus prosthesis developed by Sadra has great potential.”
Treatment of aortic valve disease remains a significant and growing unmet clinical need. As many as 3 million people in the U.S. have aortic stenosis; however, only a small percentage of those are treated with the current standard of care, open-heart valve replacement surgery, using cardiopulmonary bypass. By delivering a highly effective aortic valve replacement that reduces the risks and morbidity associated with surgery, Sadra Medical seeks to provide a therapeutic option for patients who are not being treated today.
Amr Salahieh and a small group of leading-edge cardiovascular clinicians founded Sadra Medical in 2003. Board members include Salahieh, Leslie Bottorff of Onset Ventures, Juliet Tammenoms Bakker of Pequot Ventures, David Milne of SVLS, and Fred Khosravi, CEO of Access Closure.
Leave a reply
Latest Headlines:
Friday August 31, 2012
Zscaler Secures $38 Million Investment Round
Wednesday November 30, 2011
Health Care Solutions companies Infinity Pharmaceutics, NanoVobronix and Selventa raise funds.
Monday November 21, 2011
Panda Power opens $420 Million Fund for Solar and Natural Gas Projects
Thursday November 17, 2011
Better Place raises $200 Million for Electric Cars in the Series C of Funding
Wednesday November 16, 2011
Accel Partners raise $100 Million Big Data Fund to Invest in Hadoop, NoSQL and other Companies
Tuesday November 15, 2011
Skimlinks raises $4.5 Million to help Bloggers Increase their Gains
Monday November 14, 2011
Standing Cloud raises $3 Million to help New Cloud Providers grow Faster
Thursday November 10, 2011
Zillow acquires Diverse Solutions for $7.8 to help Real Estate Agents increase their Visibility